Literature DB >> 3491987

Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1.

F D Finkelman, I M Katona, J F Urban, C M Snapper, J Ohara, W E Paul.   

Abstract

The lymphokine B-cell stimulatory factor 1 (BSF-1) has been shown to greatly enhance the differentiation of lipopolysaccharide-activated B cells into IgG1- and IgE-secreting cells in vitro. To determine whether in vivo IgG1 and IgE antibody responses are BSF-1 dependent, the ability of a monoclonal rat IgG1 anti-BSF-1 antibody, 11B11, to affect polyclonal IgG1 and IgE production in mice infected with the nematode parasite Nippostrongylus brasiliensis or injected with a purified goat antibody to mouse IgD was studied. 11B11-containing ascites fluid or purified 11B11 strongly inhibited IgE production in both systems but did not affect IgG1 production, while control ascites or normal rat IgG1 had no IgE-inhibitory activity. These results indicate an important physiologic role for BSF-1 in the generation of IgE antibody responses and suggest means for limiting the production of antibodies responsible for allergic reactions without inhibiting protective antibody responses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491987      PMCID: PMC387203          DOI: 10.1073/pnas.83.24.9675

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  IgE formation in the rat following infection with Nippostrongylus brasiliensis. I. Proliferation and differentiation of IgE-bearing cells.

Authors:  T Ishizaka; J F Urban; K Ishizaka
Journal:  Cell Immunol       Date:  1976-03-15       Impact factor: 4.868

2.  Identification of gamma-E-antibodies as a carrier of reaginic activity.

Authors:  K Ishizaka; T Ishizaka
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  Cytophilic binding of IgE to the macrophage. II. Immunologic release of lysosomal enzyme from macrophages by IgE and anti-IgE in the rat: a new mechanism of macrophage activation.

Authors:  J P Dessaint; A Capron; M Joseph; H Bazin
Journal:  Cell Immunol       Date:  1979-08       Impact factor: 4.868

Review 4.  Cellular events in the IgE antibody response.

Authors:  K Ishizaka
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

5.  Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity.

Authors:  Z Eshhar; M Ofarim; T Waks
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

6.  Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1975

7.  IgE levels in nude mice.

Authors:  K Ito; T Ogita; M Suko; M Mori; K Kudo; T Hayakawa; H Okudaira; Y Horiuchi
Journal:  Int Arch Allergy Appl Immunol       Date:  1979

8.  Time course studies on rat IgE production in N. Brasiliensis infection.

Authors:  E E Jarrett; D M Haig
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

9.  Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats.

Authors:  G P Der Balian; J Slack; B L Clevinger; H Bazin; J M Davie
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

10.  Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody.

Authors:  J J Mond; F D Finkelman; C Sarma; J Ohara; S Serrate
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

View more
  105 in total

1.  IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains.

Authors:  J D Peterson; C Waltenbaugh; S D Miller
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  IgE⁺ memory B cells and plasma cells generated through a germinal-center pathway.

Authors:  Oezcan Talay; Donghong Yan; Hans D Brightbill; Elizabeth E M Straney; Meijuan Zhou; Ena Ladi; Wyne P Lee; Jackson G Egen; Cary D Austin; Min Xu; Lawren C Wu
Journal:  Nat Immunol       Date:  2012-02-26       Impact factor: 25.606

Review 3.  Can persistent IgE responses be suppressed?

Authors:  D M Kemeny; D Diaz-Sanchez
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 4.  The role of interleukin-4 in IgE and IgG subclass formation.

Authors:  H L Spiegelberg
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 6.  Low affinity IgE receptors (Fc epsilon RII).

Authors:  D H Conrad
Journal:  Clin Rev Allergy       Date:  1989

7.  Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.

Authors:  M Radwanska; S Magez; A Michel; B Stijlemans; M Geuskens; E Pays
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.

Authors:  Eri Yasuoka; Kazuo Oshima; Katsuto Tamai; Takeshi Kubo; Yasufumi Kaneda
Journal:  J Mol Med (Berl)       Date:  2006-10-28       Impact factor: 4.599

9.  IgE production, antigen-induced airway inflammation and airway hyperreactivity in the brown Norway rat: the effects of ricin.

Authors:  S L Underwood; D M Kemeny; T H Lee; D Raeburn; J A Karlsson
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

10.  Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-gamma but not interleukin-2 production by splenic T cells.

Authors:  D Diaz-Sanchez; A Noble; D Z Staynov; T H Lee; D M Kemeny
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.